Insider Transactions in Q2 2021 at Outlook Therapeutics, Inc. (OTLK)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Apr 20 2021	Lawrence A Kenyon Chief Financial Officer	BUY Open market or private purchase	Direct	10,000 +34.57%	$10,000 $1.83 P/Share
Apr 19 2021	Faisal Ghiath Sukhtian	BUY Open market or private purchase	Direct	10,000 +33.33%	$10,000 $1.82 P/Share
Apr 19 2021	Yezan Munther Haddadin	BUY Open market or private purchase	Direct	10,000 +33.33%	$10,000 $1.82 P/Share

Receive a notification when an Institution or Guru buys or sells OTLK shares.

Notify only if

Value

Get notified when an Outlook Therapeutics, Inc. insider buys or sells OTLK shares.

Notify only if

Operation

Value

Type

Receive news related to Outlook Therapeutics, Inc.